ABSTRACT FROM: Roy A, Hechtman L, Arnold LE, et al. Childhood factors affecting persistence and desistence of attention-deficit/hyperactivity disorder symptoms in adulthood: results from the MTA. J Am Acad Child Adolesc Psychiatry 2016;55:937–44. To read the full review, log in using your NHS OpenAthens details.
Comment. Although the use of stimulants continues to increase in all age groups in the United States,1 an important debate has emerged in the last 2 years about how effective stimulants are for treating attention-deficit/hyperactivity disorder (ADHD). For some investigators, the main message in the literature is clear: the quality of evidence from randomized clinical trials on the efficacy of stimulants is poor.2 For others, the problem is in the meta-analysis from which these conclusions were taken.3 Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
To investigate the cognitive and behavioural phenotype in rare disorders of the Ras/MAPK pathway, namely Noonan, cardiofaciocutaneous (CFC), and Costello syndromes, particularly prevalence of autism spectrum disorder (ASD) and attention-deficit–hyperactivity disorder (ADHD). Please contact the library to request a copy of this article - http://bit.ly/1Xyazai
Comment. Neuroimaging has affected our understanding of psychiatric illnesses by shifting conceptualisations towards brain models of disease. However, this process has not unfolded without missteps along the way, and serious concerns about replicability continue to plague the field.1,2 From these concerns, researchers strive to find new ways to improve science, and over the years, a key takeaway point has become clear—as long as studies with small samples remain the standard, the field will continue to struggle with false positives, adding more noise to an already complex and unharmonious science. Please contact the library to request a copy of this article - http://bit.ly/1Xyazai